CH360057A - Process for the preparation of new nicotinic acid hydrazide derivatives - Google Patents

Process for the preparation of new nicotinic acid hydrazide derivatives

Info

Publication number
CH360057A
CH360057A CH360057DA CH360057A CH 360057 A CH360057 A CH 360057A CH 360057D A CH360057D A CH 360057DA CH 360057 A CH360057 A CH 360057A
Authority
CH
Switzerland
Prior art keywords
nicotinic acid
nicotinoyl
acid hydrazide
hydrazone
acid
Prior art date
Application number
Other languages
German (de)
Inventor
Hugo Dr Gutmann
Otto Dr Straub
Paul Dr Zeller
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CH360057A publication Critical patent/CH360057A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/86Hydrazides; Thio or imino analogues thereof
    • C07D213/87Hydrazides; Thio or imino analogues thereof in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)

Description

  

      Verfahren    zur     Herstellung    von neuen     Nicotinsäurehydrazid-Derivaten       Die vorliegende Erfindung betrifft ein Verfahren  zur Herstellung von neuen     Nicotinsäurehydrazid-          Derivaten    der Formel 1  
EMI0001.0006     
    worin     Ri    Wasserstoff oder die     Methylgruppe    und     R2     einen nichtaromatischen Kohlenwasserstoffrest mit  2-7     Kohlenstoffatomen    bedeuten, das dadurch ge  kennzeichnet ist,

   dass man im     Pyridinkern    gegebenen  falls     methyliertes        Nicotinsäurehydrazid    mit einer ent  sprechenden, 2-7     Kohlenstoffatome    enthaltenden       Carbonylverbindung    kondensiert und das gebildete       Hydrazon    zum     Hydrazid    reduziert. Gewünschten  falls können die erhaltenen Basen in ihre Salze über  geführt werden.  



  Die Kondensation mit der     Carbonylverbindung     und die Reduktion des erhaltenen     Nicotinoyl-          hydrazons    kann in einer oder in zwei Stufen durch  geführt werden.  



  Die Hydrierung wird zweckmässig in Gegenwart  von Katalysatoren, wie z. B. Platinoxyd,     Palladium-          kohle    usw., vorzugsweise in einem     inerten    Lösungs  mittel, vorgenommen. Gemäss einer Ausführungsform  der Erfindung kann man auch das     Nicotinoylhydrazon     mit     einer        Grignard-Verbindung    umsetzen und das  Additionsprodukt     hydrolysieren.     



  Nach dem     erfindungsgemässen    Verfahren können  beispielsweise folgende     Nicotinsäurehydrazid-Derivate          zewonnen    werden:  
EMI0001.0031     
  
    1-Nicotinoyl-2-propyl-hydrazin,
<tb>  1-Nicotinoyl-2-isobutyl-hydrazin,
<tb>  1-Nicotinoyl-2-heptyl-hydrazin,
<tb>  1-Nicotinoyl-2-isopropyl-hydrazin,
<tb>  1-Nicotinoyl-2-[butyl-(2')]-hydrazin,     
EMI0001.0032     
  
    1-Nicotinoyl-2-[pentyl-(3')] <SEP> hydrazin,
<tb>  1-Nicotinoyl-2-[4'-methyl-pentyl-(2')]-hydrazin,
<tb>  1-Nicotinoyl-2-cyclopropyl-hyd'razin,
<tb>  1-Nicotinoyl-2-cyclohexyl-hydrazin,
<tb>  1-Nicotinoyl-2-(a-cyclopentyl-äthyl)-hydrazin,
<tb>  1-Nicotinoyl-2-tert. <SEP> butyl-hydrazin,
<tb>  1-(6'-Methyl-nicotinoyl)-2-isopropyl-hydrazin,
<tb>  1-Nicotinoyl-2-cyclopentyl-hydrazin.

         Die erfindungsgemäss erhältlichen     Nicotinsäure-          hydrazid-Derivate    bilden wohldefinierte Salze, sowohl  mit anorganischen Säuren, z. B. mit Halogenwasser  stoffsäuren, wie     Chlorwasserstoffsäure,    Bromwasser  stoffsäure,     Jodwasserstoffsäure,        mit    andern Mineral  wasserstoffsäuren, wie Schwefelsäure, Phosphorsäure  oder Salpetersäure, als auch     mit    organischen Säuren,  wie Weinsäure,     Citronensäure,        Camphersulfosäure,          Athansulfosäure,        Salicylsäure,    Ascorbinsäure, Ma  leinsäure, Mandelsäure usw.

   Bevorzugte     Salze    sind  die     Hydrohalogenide,    insbesondere die     Hydrochloride.     Die     Säureadditionssalze    werden vorzugsweise in  einem     inerten    Lösungsmittel durch Behandlung des       Hydrazinderivates    mit einem     überschuss    der entspre  chenden Säure hergestellt.  



  Die     erfindunggemäss    erhältlichen Verfahrens  produkte und deren     Salze    hemmen die Mono  aminoxydase; einzelne Vertreter zeichnen sich durch       ihre    ausgeprägte     antidepressive    Wirksamkeit aus und       wirken    bei Kachexie gewichtssteigernd. Sie stellen  damit eine     wertvolle    Bereicherung des Arzneimittel  schatzes dar.  



  <I>Beispiel 1</I>       1-Nicotinoyl-2-isopropyl-hydrazin     40g     Nicotinsäurehydrazid    werden in 650     em3     Aceton bis zur klaren Lösung gekocht, worauf zur  Trockne eingedampft, der Rückstand auf Ton     ger     trocknet und einmal aus     Benzol/Aceton    5 :

   1 um-      kristallisiert wird. 40 g des so erhaltenen 1     Nico-          tinoyl    2     isopropyliden-hydrazins    werden in 1000     cm3     Methanol unter Zusatz von Platinoxyd unter Normal  bedingungen bis zur Aufnahme der berechneten  Menge     Wasserstoff        hydriert    (1     Mol    pro     Mol    einge  setzter Substanz). Das eingeengte Filtrat wird in  500     cm3        Athanol    aufgenommen, mit 32 g     Oxalsäure          versetzt    und nach dem Kühlen im Eisschrank durch       Filtrieren    geklärt.

   Aus dem     Filtrat    fallen nach neuer  lichem     Aufbewahren    in der Kälte 17 g rohes     Oxalat     aus, die mehrmals aus Äthanol unter Zusatz von  Tierkohle     umkristallisiert    werden. Man erhält so  1 -     Nicotinoyl    - 2 -     isopropyl    -     hydrazin    in Form des       Sesqui-oxalates    vom     Schmelzpunkt    139-141 .  



  <I>Beispiel 2</I>       1-(6'-Methyl-nicotinoyl)-2-isopropyl-hydrazin     15 g 6 -     Methyl    -     nicotinsäurehydrazid,    erhalten  durch Umsetzung von 6     Methyl-nicotinsäureäthyl-          ester    mit     Hydrazinhydrat        in        äthanolischer        Lösung,     werden mit 250 cm s Aceton 3 Stunden gekocht, im  Vakuum zur Trockne eingeengt und der Rückstand  aus     Benzol        umkristallisiert.    Die erhaltenen 15 g       1-(6'-Methyl-nicotinoyl)

  -2-isopropyliden-hydrazin     werden in 300     em3    Äthanol unter Zusatz von Platin  oxyd unter Normalbedingungen bis zur Aufnahme  der berechneten Menge Wasserstoff hydriert. Das  vom Katalysator     abgenutschte    Filtrat     wird    im Vakuum  zur Trockne gebracht und der Rückstand einige  Male aus     Petroläther/Äthanol    umkristallisiert. Man  erhält so 1- (6' -     Methyl    -     nicotinoyl)    - 2 -     isopropyl-          hydrazin    vom Schmelzpunkt 117-118,5 .  



  <I>Beispiel 3</I>       1-Nicotinoyl-2-cyclohexyl-hydrazin     20 g     Nicotinsäurehydrazid    und .11 g     Cyclo-          hexanon    werden in 300     cm3    Äthanol unter Zusatz  von Platinoxyd bei Normalbedingungen bis zur Auf  nahme von einem Äquivalent     Wasserstoff        hydriert.     Das vom Katalysator     abgenutschte    Filtrat wird im  Vakuum zur Trockne gebracht und der Rückstand  aus     Petroläther    umkristallisiert. Das erhaltene 1-Ni-         cotinoyl-2-cyclohexyl-hydrazin    schmilzt bei 119 bis  121 .



      Process for the production of new nicotinic acid hydrazide derivatives The present invention relates to a process for the production of new nicotinic acid hydrazide derivatives of the formula 1
EMI0001.0006
    where Ri is hydrogen or the methyl group and R2 is a non-aromatic hydrocarbon radical with 2-7 carbon atoms, which is characterized

   that if necessary methylated nicotinic acid hydrazide is condensed in the pyridine nucleus with a corresponding carbonyl compound containing 2-7 carbon atoms and the hydrazone formed is reduced to the hydrazide. If desired, the bases obtained can be converted into their salts.



  The condensation with the carbonyl compound and the reduction of the nicotinoyl hydrazone obtained can be carried out in one or in two stages.



  The hydrogenation is conveniently carried out in the presence of catalysts, such as. B. platinum oxide, palladium carbon, etc., preferably in an inert solvent medium, made. According to one embodiment of the invention, the nicotinoyl hydrazone can also be reacted with a Grignard compound and the addition product can be hydrolyzed.



  The following nicotinic acid hydrazide derivatives, for example, can be obtained using the process according to the invention:
EMI0001.0031
  
    1-nicotinoyl-2-propyl-hydrazine,
<tb> 1-nicotinoyl-2-isobutylhydrazine,
<tb> 1-nicotinoyl-2-heptyl-hydrazine,
<tb> 1-nicotinoyl-2-isopropyl-hydrazine,
<tb> 1-nicotinoyl-2- [butyl- (2 ')] - hydrazine,
EMI0001.0032
  
    1-nicotinoyl-2- [pentyl- (3 ')] <SEP> hydrazine,
<tb> 1-nicotinoyl-2- [4'-methyl-pentyl- (2 ')] - hydrazine,
<tb> 1-nicotinoyl-2-cyclopropyl-hyd'razine,
<tb> 1-nicotinoyl-2-cyclohexylhydrazine,
<tb> 1-nicotinoyl-2- (a-cyclopentyl-ethyl) -hydrazine,
<tb> 1-nicotinoyl-2-tert. <SEP> butyl hydrazine,
<tb> 1- (6'-Methyl-nicotinoyl) -2-isopropyl-hydrazine,
<tb> 1-Nicotinoyl-2-cyclopentylhydrazine.

         The nicotinic acid hydrazide derivatives obtainable according to the invention form well-defined salts, both with inorganic acids, e.g. B. with hydrogen halide acids such as hydrochloric acid, hydrobromic acid, hydroiodic acid, with other mineral hydrochloric acids such as sulfuric acid, phosphoric acid or nitric acid, and with organic acids such as tartaric acid, citric acid, camphorsulfonic acid, athanesulfonic acid, salicylic acid, ascorbic acid, maleic acid, mandelic acid, etc. .

   Preferred salts are the hydrohalides, especially the hydrochlorides. The acid addition salts are preferably prepared in an inert solvent by treating the hydrazine derivative with an excess of the corresponding acid.



  The process products obtainable according to the invention and their salts inhibit mono amine oxidase; individual representatives are characterized by their pronounced antidepressant effectiveness and have a weight-increasing effect in cachexia. They thus represent a valuable addition to the medicinal treasure trove.



  <I> Example 1 </I> 1-Nicotinoyl-2-isopropylhydrazine 40g nicotinic acid hydrazide are boiled in 650 cubic meters of acetone until a clear solution is obtained, whereupon it is evaporated to dryness, the residue is dried on clay and once from benzene / acetone 5:

   1 is recrystallized. 40 g of the 1 nicotinoyl 2 isopropylidene hydrazine obtained in this way are hydrogenated in 1000 cm3 of methanol with the addition of platinum oxide under normal conditions until the calculated amount of hydrogen is absorbed (1 mole per mole of substance used). The concentrated filtrate is taken up in 500 cm3 of ethanol, 32 g of oxalic acid are added and, after cooling in the refrigerator, it is clarified by filtration.

   After renewed storage in the cold, the filtrate precipitates 17 g of crude oxalate, which are recrystallized several times from ethanol with the addition of animal charcoal. 1 - Nicotinoyl - 2 - isopropyl - hydrazine is thus obtained in the form of sesqui-oxalate with a melting point of 139-141.



  <I> Example 2 </I> 1- (6'-methyl-nicotinoyl) -2-isopropyl-hydrazine 15 g of 6-methyl-nicotinic acid hydrazide, obtained by reacting 6 methyl-nicotinic acid ethyl ester with hydrazine hydrate in an ethanolic solution boiled with 250 cm s acetone for 3 hours, concentrated to dryness in vacuo and the residue was recrystallized from benzene. The 15 g of 1- (6'-methyl-nicotinoyl) obtained

  -2-isopropylidene hydrazine are hydrogenated in 300 cubic meters of ethanol with the addition of platinum oxide under normal conditions until the calculated amount of hydrogen is absorbed. The filtrate filtered off with suction from the catalyst is brought to dryness in vacuo and the residue is recrystallized a few times from petroleum ether / ethanol. 1- (6'-methyl-nicotinoyl) -2-isopropylhydrazine with a melting point of 117-118.5 is obtained in this way.



  <I> Example 3 </I> 1-Nicotinoyl-2-cyclohexylhydrazine 20 g of nicotinic acid hydrazide and 11 g of cyclohexanone are hydrogenated in 300 cm3 of ethanol with the addition of platinum oxide under normal conditions until one equivalent of hydrogen is taken up. The filtrate filtered off with suction from the catalyst is brought to dryness in vacuo and the residue is recrystallized from petroleum ether. The 1-nicotinoyl-2-cyclohexylhydrazine obtained melts at 119 to 121.

 

Claims (1)

PATENTANSPRUCH Verfahren zur Herstellung von neuen Nicotin- säurehydrazid-Derivaten der Formel EMI0002.0055 worin R, Wasserstoff oder die Methylgruppe und R, einen nichtaromatischen Kohlenwasserstoffrest mit 2-7 Kohlenstoffatomen bedeuten, dadurch ge kennzeichnet, dass man im Pyridinkern gegebenen falls methyliertes Nicotinsäurehydrazid mit einer ent sprechenden, PATENT CLAIM Process for the production of new nicotinic acid hydrazide derivatives of the formula EMI0002.0055 where R, hydrogen or the methyl group and R, a non-aromatic hydrocarbon radical with 2-7 carbon atoms, characterized in that, if appropriate, methylated nicotinic acid hydrazide with a corresponding, 2-7 Kohlenstoffatome enhaltenden Carbonylverbindung kondensiert und das gebildete Hydrazon zum Hydrazid reduziert. UNTERANSPRÜCHE 1. Verfahren nach Patentanspruch, dadurch ge kennzeichnet, dass man das erhaltene Hydrazid in ein Salz überführt. 2. Verfahren nach Patentanspruch, dadurch ge kennzeichnet, dass man die Kondensation und Re duktion in zwei Stufen durchführt. 3. Condensed carbonyl compound containing 2-7 carbon atoms and reduced the hydrazone formed to the hydrazide. SUBClaims 1. Process according to claim, characterized in that the hydrazide obtained is converted into a salt. 2. The method according to claim, characterized in that the condensation and reduction are carried out in two stages. 3. Verfahren nach Patentanspruch, dadurch ge kennzeichnet, dass man die Kondensation und Re duktion in einer Stufe durchführt. 4. Verfahren nach Patentanspruch und Unter ansprüchen 2 und 3, dadurch gekennzeichnet, dass man das Hydrazon katalytisch, zum Beispiel in Ge genwart von Platinoxyd oder Palladiumkohle, hy driert. 5. Process according to claim, characterized in that the condensation and reduction are carried out in one stage. 4. The method according to claim and sub-claims 2 and 3, characterized in that the hydrazone is catalytically, for example, in the presence of platinum oxide or palladium-carbon, hydrated. 5. Verfahren nach Patentanspruch, dadurch ge kennzeichnet, dass man das Hydrazon mit einer Grignard-Verbindung behandelt und das gebildete Additionsprodukt hydrolysiert. 6. Verfahren nach Patentanspruch und den Un teransprüchen 1-5, dadurch gekennzeichnet, dass man als Carbonylverbindung Aceton verwendet. Process according to claim, characterized in that the hydrazone is treated with a Grignard compound and the addition product formed is hydrolyzed. 6. The method according to claim and the un terclaims 1-5, characterized in that acetone is used as the carbonyl compound.
CH360057D 1957-04-09 1957-04-09 Process for the preparation of new nicotinic acid hydrazide derivatives CH360057A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH360057T 1957-04-09

Publications (1)

Publication Number Publication Date
CH360057A true CH360057A (en) 1962-02-15

Family

ID=4512475

Family Applications (1)

Application Number Title Priority Date Filing Date
CH360057D CH360057A (en) 1957-04-09 1957-04-09 Process for the preparation of new nicotinic acid hydrazide derivatives

Country Status (1)

Country Link
CH (1) CH360057A (en)

Similar Documents

Publication Publication Date Title
CH360057A (en) Process for the preparation of new nicotinic acid hydrazide derivatives
AT203500B (en) Process for the preparation of new nicotinic acid hydrazide derivatives
DE934651C (en) Process for the preparation of tetrasubstituted diaminoalkanes
AT203499B (en) Process for the preparation of new heterocyclic hydrazine derivatives
AT258947B (en) Process for the preparation of new substituted hydrazine compounds and their salts
AT219583B (en) Process for the preparation of disubstituted carboxylic acid hydrazides
AT205976B (en) Process for the preparation of new nicotinic acid hydrazide derivatives
AT208349B (en) Process for the preparation of new substituted acid hydrazides
AT218520B (en) Process for the preparation of new piperidine and tetrahydropyridine derivatives
AT208348B (en) Process for the preparation of new substituted acid hydrazides
AT210881B (en) Process for the production of new phthalimido tert. aminoacylophenones and their salts
AT237623B (en) Process for the preparation of new benzodiazepine derivatives
DE1445872C (en) 5 phenyl 1,2 dihydro 3H 1,4 benzodi azepinone (2) derivatives
AT222104B (en) Process for the preparation of new cyclobutane derivatives
AT201580B (en) Process for the production of new, secondary amines
AT204036B (en) Process for the preparation of new (N-alkyl-piperidone) acylhydrazones
AT225197B (en) Process for the preparation of the new N- [p-3,3-disubstituted-1-azetidinylethoxy) benzyl] -3,4,5-trimethoxybenzamides
AT208867B (en) Process for the preparation of new substituted heterocyclic acid hydrazides
DE1643506C (en) N to the power of 1 acylphenyl hydrazine, their salts, process for their preparation and medicinal products containing these compounds, by means of excretion from 1620441
AT210884B (en) Process for the production of new phthalimido tert. aminoacylophenones and their salts
CH456631A (en) Process for the preparation of substituted hydrazine compounds
AT217034B (en) Process for the preparation of new substituted heterocyclic acid hydrazides
AT235283B (en) Process for the preparation of new indole compounds
AT233017B (en) Process for the preparation of new iminodibenzyl derivatives
AT255409B (en) Process for the preparation of new substituted benzimidazole derivatives and their salts